title: Rearrangement of the cone mosaic in the retina of the rat model of retinitis pigmentosa.
abstract: In retinitis pigmentosa (RP), the death of cones normally follows some time after the degeneration of rods. Recently, surviving cones in RP have been studied and reported in detail. These cones undergo extensive remodeling in their morphology. Here we report an extension of the remodeling study to consider possible modifications of spatial-distribution patterns. For this purpose we used S334ter-line-3 transgenic rats, a transgenic model developed to express a rhodopsin mutation causing RP. In this study, retinas were collected at postnatal (P) days P5-30, 90, 180, and P600. We then immunostained the retinas to examine the morphology and distribution of cones and to quantify the total cone numbers. Our results indicate that cones undergo extensive changes in their spatial distribution to give rise to a mosaic comprising an orderly array of rings. These rings first begin to appear at P15 at random regions of the retina and become ubiquitous throughout the entire tissue by P90. Such distribution pattern loses its clarity by P180 and mostly disappears at P600, at which time the cones are almost all dead. In contrast, the numbers of cones in RP and normal conditions do not show significant differences at stages as late as P180. Therefore, rings do not form by cell death at their centers, but by cone migration. We discuss its possible mechanisms and suggest a role for hot spots of rod death and the remodeling of Müller cell process into zones of low density of photoreceptors.
authors.affiliation: Neuroscience Graduate Program, University of Southern California, Los Angeles, California 90089-1111, USA.
authors.forename: Yerina
authors.initials: Y
authors.lastname: Ji
authors.forename: Colleen L
authors.initials: CL
authors.lastname: Zhu
authors.forename: Norberto M
authors.initials: NM
authors.lastname: Grzywacz
authors.forename: Eun-Jin
authors.initials: EJ
authors.lastname: Lee
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D016923:Cell Death / Q000502:physiology; D002460:Cell Line; D004396:Coloring Agents; D018450:Disease Progression; D006416:Hematoxylin; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D055355:Opsins / Q000276:immunology / Q000378:metabolism; D018809:Proliferating Cell Nuclear Antigen / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D055647:Rats, Transgenic; D012160:Retina / Q000254:growth & development / Q000473:pathology; D017949:Retinal Cone Photoreceptor Cells / Q000473:pathology*; D012174:Retinitis Pigmentosa / Q000473:pathology*; D012243:Rhodopsin / Q000235:genetics / Q000378:metabolism
chemical_list: D000906:Antibodies; D004396:Coloring Agents; D055355:Opsins; D018809:Proliferating Cell Nuclear Antigen; D012243:Rhodopsin; D006416:Hematoxylin
references.citation: Science. 1988 Jun 10;240(4858):1544-6
references.pmid: 2897717
references.citation: Exp Eye Res. 2002 Mar;74(3):327-36
references.pmid: 12014914
references.citation: Neuroscience. 2008 Aug 26;155(3):698-713
references.pmid: 18639614
references.citation: Nat Genet. 1992 Jun;1(3):209-13
references.pmid: 1303237
references.citation: Diabetes. 2010 Nov;59(11):2872-82
references.pmid: 20693346
references.citation: J Comp Neurol. 1982 Dec 10;212(3):217-30
references.pmid: 7153374
references.citation: J Comp Neurol. 2006 Jun 1;496(4):544-55
references.pmid: 16572432
references.citation: Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1600-8
references.pmid: 9699549
references.citation: Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1516-24
references.pmid: 15790924
references.citation: Prog Retin Eye Res. 1998 Apr;17(2):175-205
references.pmid: 9695792
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7103-8
references.pmid: 9618546
references.citation: Biol Cell. 2004 May;96(4):261-9
references.pmid: 15145530
references.citation: Cell Tissue Res. 1996 May;284(2):193-202
references.pmid: 8625386
references.citation: Exp Eye Res. 1997 Jul;65(1):45-50
references.pmid: 9237863
references.citation: Mol Vis. 2002 Aug 27;8:306-14
references.pmid: 12355062
references.citation: Exp Eye Res. 2010 Jul;91(1):54-62
references.pmid: 20398652
references.citation: Am J Ophthalmol. 1970 Mar;69(3):339-49
references.pmid: 4190798
references.citation: Exp Eye Res. 1975 Aug;21(2):167-92
references.pmid: 1164921
references.citation: Glia. 2011 Jul;59(7):1107-17
references.pmid: 21547953
references.citation: Am J Anat. 1972 May;134(1):5-21
references.pmid: 5031977
references.citation: J Comp Neurol. 2011 May 1;519(7):1258-80
references.pmid: 21452196
references.citation: Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3557-66
references.pmid: 21273547
references.citation: Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4097-104
references.pmid: 12939333
references.citation: Invest Ophthalmol Vis Sci. 2006 May;47(5):2080-92
references.pmid: 16639019
references.citation: Mol Neurobiol. 2003 Oct;28(2):139-47
references.pmid: 14576452
references.citation: Invest Ophthalmol Vis Sci. 1996 Apr;37(5):753-65
references.pmid: 8603860
references.citation: Glia. 2003 Jul;43(1):70-6
references.pmid: 12761869
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13654-9
references.pmid: 15353594
references.citation: PLoS One. 2010 Mar 02;5(3):e9495
references.pmid: 20209167
references.citation: J Neurosci. 2005 Jun 1;25(22):5438-45
references.pmid: 15930394
references.citation: Neurosci Lett. 1987 Aug 18;79(1-2):78-84
references.pmid: 3670734
references.citation: Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9938-43
references.pmid: 9707579
references.citation: Vision Res. 2008 Feb;48(3):442-52
references.pmid: 17949773
references.citation: J Comp Neurol. 1974 Jul 1;156(1):95-106
references.pmid: 4836657
references.citation: Nat Genet. 1997 Feb;15(2):216-9
references.pmid: 9020854
references.citation: J Biol Chem. 1986 Sep 15;261(26):12310-6
references.pmid: 3745189
references.citation: Eur J Neurosci. 2005 Nov;22(10):2481-8
references.pmid: 16307591
references.citation: J Neurosci. 2003 Jul 9;23(14):6152-60
references.pmid: 12853434
references.citation: Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2897-904
references.pmid: 16043864
references.citation: Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2799-805
references.pmid: 17525215
references.citation: Nat Neurosci. 2001 Mar;4(3):247-52
references.pmid: 11224540
references.citation: Exp Eye Res. 2009 Dec;89(6):913-20
references.pmid: 19660451
references.citation: Invest Ophthalmol Vis Sci. 2004 Mar;45(3):971-6
references.pmid: 14985319
references.citation: Exp Eye Res. 2009 Mar;88(3):589-99
references.pmid: 19087876
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8461-6
references.pmid: 15148406
references.citation: Brain Res. 2010 Mar 19;1321:60-6
references.pmid: 20114037
references.citation: Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1691-9
references.pmid: 2759786
references.citation: Science. 1974 Nov 1;186(4162):449-51
references.pmid: 4369896
references.citation: Exp Eye Res. 2003 Apr;76(4):463-71
references.pmid: 12634111
references.citation: Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8641-5
references.pmid: 1717982
references.citation: J Comp Neurol. 2008 Mar 20;507(3):1336-50
references.pmid: 18189305
references.citation: EMBO J. 1987 Mar;6(3):637-42
references.pmid: 2884104
references.citation: Lancet. 2006 Nov 18;368(9549):1795-809
references.pmid: 17113430
references.citation: Invest Ophthalmol Vis Sci. 1978 Jun;17(6):489-98
references.pmid: 659071
references.citation: Genomics. 1993 Apr;16(1):45-9
references.pmid: 8486383
references.citation: J Cell Sci. 2004 Aug 15;117(Pt 18):4169-77
references.pmid: 15316081
references.citation: Graefes Arch Clin Exp Ophthalmol. 1996 Nov;234(11):695-702
references.pmid: 8950590
references.citation: Biochemistry. 1983 Feb 1;22(3):653-60
references.pmid: 6188482
references.citation: Eye (Lond). 2011 Mar;25(3):301-8
references.pmid: 21390064
references.citation: Br J Ophthalmol. 1933 Jun;17(6):321-36
references.pmid: 18169123
references.citation: Nature. 1990 Oct 18;347(6294):677-80
references.pmid: 1977087
references.citation: Cell Tissue Res. 2010 Mar;339(3):481-91
references.pmid: 20127257
references.citation: J Comp Neurol. 2011 Feb 15;519(3):467-79
references.pmid: 21192079
references.citation: J Neurochem. 2009 Jan;108(1):91-101
references.pmid: 19014374
references.citation: Diabetes. 2003 Mar;52(3):857-63
references.pmid: 12606531
references.citation: Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3876-82
references.pmid: 16186377
references.citation: Neurosci Lett. 1995 Feb 24;187(1):33-6
references.pmid: 7617296
references.citation: Dev Biol. 2008 May 15;317(2):560-75
references.pmid: 18417110
references.citation: Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4968-75
references.pmid: 14578424
references.citation: Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3283-91
references.pmid: 17591900
references.citation: Invest Ophthalmol. 1974 May;13(5):334-9
references.pmid: 4823176
references.citation: Nature. 1987 Apr 2-8;326(6112):515-7
references.pmid: 2882423
references.citation: J Neurosci. 2008 Apr 9;28(15):4008-14
references.pmid: 18400900
references.citation: Gerontology. 2003 Nov-Dec;49(6):350-5
references.pmid: 14624063
references.citation: Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3511-21
references.pmid: 12407163
references.citation: J Neurosci. 1998 Jun 1;18(11):4076-82
references.pmid: 9592088
references.citation: Cancer Res. 1999 Apr 1;59(7 Suppl):1731s-1735s
references.pmid: 10197588
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8484-8
references.pmid: 8378322
references.citation: J Cell Sci. 1990 May;96 ( Pt 1):121-9
references.pmid: 1695635
references.citation: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1864-72
references.pmid: 17389522
references.citation: Invest Ophthalmol Vis Sci. 1998 Mar;39(3):592-602
references.pmid: 9501871
references.citation: Exp Eye Res. 1994 Apr;58(4):397-408
references.pmid: 7925677
references.citation: Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1659-76
references.pmid: 8473105